MedPath

To see the effects of injection of Platelet-rich plasma (Blood component of the same patient)in gums on the speed of tooth movement in patients under orthodontic treatment.

Not yet recruiting
Conditions
Disease of hard tissues of teeth,unspecified,
Registration Number
CTRI/2020/08/027212
Lead Sponsor
Government Dental College and Hospital Nagpur
Brief Summary

Orthodontic tooth movement is described as a process ofcontinuous remodeling of tissues surrounding the root. Thisremodelling takes place under the mechanical forces applied duringorthodontic treatment. One of the major concerns of orthodontic treatment is its longerduration. To counteract this problem, there has occurred a need toincrease the rate of tooth movement. Accelerating orthodontictooth movement has long been desired for its multiple potentialbenefits, including shorter treatment duration, reduced side effects(such as oral hygiene-related problems, root resorption, and opengingival embrasure spaces), enhanced envelope of tooth movement,differential tooth movement, and improved posttreatmentstabilityâ€. Various methods that can increase the rate of orthodontic toothmovement and reduce the treatment time, include non-surgicalmethods like low-intensity laser therapy, local injections ofprostaglandins, 1, 25(OH)2D3 (the active form of vitamin D3),osteocalcin and relaxin around the alveolar socket. othermethods as electric stimulation and resonance vibration havebeen tried. Surgical methods mainly include corticotomy -facilitatedtooth movement. Platelet-rich plasma (PRP) is an autologous component of blood witha high concentration of platelets and has shown to accelerateorthodontic tooth movement. Platelets, in turn, have α-granules which are the source for many growth factors and the amount ofwhich is higher in PRP when compared to serum. Due to thepresence of a large amount of these growth factors within the PRPthere is faster bone repair and acceleration of tooth. As such, PRPcontains not only a high level of platelets but also the fullcomplement of clotting factors and secretory proteins. The sevenknown growth factors in PRP are Platelet-derived growth factor asPDGFαα, PDGFαβ, PDGFββ, transforming growth factor-beta-TGF-β1,TGF-β2, Vascular endothelial growth factor (VEGF) and epithelialgrowth factor (EGF). Platelet-derived growth factor (PDGF) is released upon activation ofosteoblasts, results in an increase of new bone formation. PDGFinitially stimulates bone resorption and stimulates the proliferationand chemotaxis of osteoblasts. Thus, functions as an anabolic factorin bone metabolism. Vascular endothelial growth factor (VEGF), is an angiogenicmediator, is believed to play a critical role in skeletal developmentby enhancement of angiogenesis. TGF can stimulate both osteoblastic and osteoclastic activities.PRP along with growth factors also have a rich content of cytokinesthat have a major role during orthodontic tooth movementthroughout mediating differentiation, activation, and survival of allbone cells supported the idea that PRP could have a possible effecton orthodontic tooth movement. As PRP includes a patient’s own platelets, the risk of transmissiblediseases and adverse reactions is reduced making PRP a safe andefficient method of accelerating orthodontic tooth movement. To simulate the effects of surgical insult without surgery, the localinjection of cytokines or hormones could be a substitute for surgical insults, but it is not practical clinically due to its systemiceffects and the need for frequent injections. Injection of autologous platelet-rich plasma (PRP) could be a better substitute for bonesurgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Patients indicated for orthodontic treatment with extraction of 1st premolars of both sides.
  • Patients indicated for fixed mechanotherapy.
Exclusion Criteria
  • Patients with systemic disease.
  • Patients on Non-steroidal anti-inflammatory therapy/ vitamin D derivatives 3.
  • Periodontally compromised patients.
  • Impacted canines.
  • Canines with dilacerated roots.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Asses the rate of canine tooth movementBaseline, 3 months,6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Government Dental College and Hospital, Nagpur

🇮🇳

Nagpur, MAHARASHTRA, India

Government Dental College and Hospital, Nagpur
🇮🇳Nagpur, MAHARASHTRA, India
Dr Kanchan Narkhede
Principal investigator
9765270888
kanchananarkhede3125@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.